Prosecution Insights
Prosecution Insights
140 pending office actions • 94 clients • 128 examiners • 66 art units • 0 of 140 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 54 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 54 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (1%) |
| §101 + other | 18 (13%) |
| §103 only | 32 (23%) |
| §102 only | 9 (6%) |
| §112 only | 7 (5%) |
| Double-patenting only | 5 (4%) |
| Double-patenting + other | 20 (14%) |
| Multi-statute (no §101) | 46 (33%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GROOMS, TIFFANY NICOLE | 3 | 59.1% | +46.3% |
| GOUGH, TIFFANY MAUREEN | 2 | 31.3% | +47.1% |
| GUSTILO, ESTELLA M | 2 | 53.2% | +36.8% |
| MUI, CHRISTINE T | 2 | 78.2% | +20.0% |
| ZARA, JANE J | 2 | 70.8% | +16.1% |
| LYLE, SOPHIA YUAN | 2 | 57.7% | +59.0% |
| SCOTLAND, REBECCA LYNN | 2 | 0.0% | +0.0% |
| JUEDES, AMY E | 2 | 45.0% | +41.4% |
| GAMBLE JR, RANDALL LEE | 2 | 50.0% | +25.8% |
| CRAIG, KAILA ANGELIQUE | 2 | 32.8% | +26.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18361156 | MODULAR MULTI-PANEL SOLAR CELL | CANNON, RYAN SMITH | 114d overdue |
| 17262400 | METHOD FOR PRODUCING FOREIGN ANTIGEN RECEPTOR GENE-INTRODUCED CELL | MIANO, JOSEPH PAUL | 87d overdue |
| 17996126 | LONG ACTING GLUCAGON RECEPTOR SELECTIVE PEPTIDES AND METHODS OF USE | KONOPELSKI SNAVEL, SARA ELIZABETH | 49d overdue |
| 18201626 | USE OF ANTI-IL-27 ANTIBODIES | JOHNSON, TIRONE DEREK | 45d overdue |
| 18649142 | REACTIONS USING FACILITATORS AND MODERATORS | GARNER, LILY CRABTREE | 37d overdue |
| 18062311 | CENTRIFUGE APHERETIC SYSTEM | KASS, BENJAMIN JOSEPH | 35d overdue |
| 18039091 | NON AGGREGATING MICROFLUIDIC MIXER AND METHODS THEREFOR | INSLER, ELIZABETH | 11d overdue |
| 18439838 | FUNTIONALLY MODIFIED POLYPEPTIDES AND RADIOBIOSYNTHESIS | STEELE, AMBER D | 9d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17796953 | METHOD FOR FUNCTIONALISING A CELLULOSE SUPPORT WITH METAL NANOPARTICLES AND ELECTROANALYTICAL SENSOR COMPRISING THE FUNCTIONALISED CELLULOSE SUPPORT | GAMBLE JR, RANDALL LEE | 46d overdue |
| 17313421 | Biological Fluid Filtration System | LYLE, SOPHIA YUAN | 30d overdue |
| 18299304 | THERAPEUTIC RADIOLABELLED CONJUGATES AND THEIR USE IN THERAPY | CRAIG, KAILA ANGELIQUE | 23d overdue |
| 18252896 | METHOD FOR DETECTING AND/OR QUANTIFYING A METAL ELEMENT IN A BIOLOGICAL LIQUID | GAMBLE JR, RANDALL LEE | 14d |
| 18040321 | TESTING DEVICE WITH BUILT-IN LIQUID STORAGE | MUI, CHRISTINE T | 29d |
| 18322675 | SYSTEMS, METHODS, AND COMPOSITIONS FOR RNA-GUIDED RNA-TARGETING CRISPR EFFECTORS | GROOMS, TIFFANY NICOLE | 42d |
| 18038818 | ANTIBODY AND TAXANE COMBINATION THERAPY | JUEDES, AMY E | 75d |
| 19224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | — |
| Art Unit | Apps |
|---|---|
| 1637 | 7 |
| 1618 | 7 |
| 1635 | 6 |
| 1654 | 5 |
| 1613 | 3 |
| 1651 | 3 |
| 1621 | 3 |
| 1625 | 3 |
| 1642 | 3 |
| 1643 | 3 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19439605 | REFURBISHED STEERABLE DRIVE AXLE ASSEMBLY DERIVED FROM A MILITARY DRIVE AXLE | Custom Truck One Source, Inc. | KNAUF, MORGAN MARIE | 3611 | §103 | Final Rejection | — | Pending | Jan 05, 2026 |
| 19355164 | EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS | Filamon Ltd. | ESPINOSA, CLAUDIA EDILMA | 1654 | §102 | Final Rejection | 22d | Pending | Oct 10, 2025 |
| 19337639 | METHOD FOR PRODUCING A LIQUID COMPOSITION INCLUDING A NANOPARTICLE, AND FORMULATION THEREOF | Global Life Sciences Solutions UK Limited | PHAN, DOAN THI-THUC | 1613 | §102§103 | Non-Final OA | 84d | Pending | Sep 23, 2025 |
| 19271284 | PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE | Scpharmaceuticals Inc. | HUANG, GIGI GEORGIANA | 1613 | §103DP | Final Rejection | 7d | Pending | Jul 16, 2025 |
| 19137361 | MEASUREMENT DEVICE AND DRILL GUIDE | Arthrex, Inc. | SIPP, AMY R. | 3775 | §102§103§112 | Non-Final OA | — | Pending | Jun 10, 2025 |
| 19224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | Wageningen Universiteit | GOUGH, TIFFANY MAUREEN | 1651 | §101DP | Final Rejection | — | Pending | May 30, 2025 |
| 19203683 | MOBILE SURVEILLANCE SYSTEM FOR REAL-TIME DETECTION AND PREDICTION OF TRAFFIC VIOLATIONS | Vig Vehicle Intelligence Group LLC | AFRIFA-KYEI, ANTHONY D | §101§102§103 | Non-Final OA | — | Pending | May 09, 2025 | |
| 19083908 | SYSTEMS AND METHODS FOR SUPPORTING HEALTH-BASED COMMUNICATIONS | Sequelae, Inc. | SIOZOPOULOS, CONSTANTINE B | §101§102 | Non-Final OA | — | Pending | Mar 19, 2025 | |
| 19042537 | SYSTEM AND METHOD FOR A BOOM CRANE WITH AN EXTENSIBLE POWER SOURCE ANCHORED ONLY TO THE FIRST SECTION | Custom Truck One Source, Inc. | CAMPOS JR, JUAN J | §101§112 | Non-Final OA | — | Pending | Jan 31, 2025 | |
| 19027749 | MICROPHONE ANTENNA SYSTEM INCLUDING WINDSHIELD STRUCTURE | Freedman Electronics Pty Ltd. | LOTTER, DAVID E | 2845 | §103 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18932344 | SYSTEMS AND METHODS FOR COHERENT PASSIVE OPTICAL NETWORKS | Cable Television Laboratories, Inc. | BROCK, PAUL MORGAN | §102§103 | Non-Final OA | — | Pending | Oct 30, 2024 | |
| 18925317 | SYSTEMS AND METHODS FOR RECONFIGURABLE COHERENT PON | Cable Television Laboratories, Inc. | PHAN, HANH | §103 | Non-Final OA | — | Pending | Oct 24, 2024 | |
| 18841615 | SYSTEMS AND METHODS FOR CAPILLARY ISOELECTRIC FOCUSING-MASS SPECTROMETRY (CIEF-MS) ISOELECTRIC POINT (pI) CALIBRATION | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | WANG, JING | §103 | Non-Final OA | — | Pending | Aug 26, 2024 | |
| 18835285 | AUTONOMOUS SYSTEM TRAINING AND TESTING | Waabi Innovation Inc. | TSWEI, YU-JANG | 2614 | §103 | Non-Final OA | 9d | Pending | Aug 01, 2024 |
| 18787371 | PLASMA-DERIVED NANOPARTICLES | Nanomedx, Inc. | CABRAL, ROBERT S | DP | Non-Final OA | — | Pending | Jul 29, 2024 | |
| 18832725 | LIQUID FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A | Hanmi Pharm. Co., Ltd. | CRAIGO, WILLIAM A | §103§112DP | Non-Final OA | — | Pending | Jul 24, 2024 | |
| 18780957 | HIDDEN EDGE FOR FLOORING FINISHING | Columbia Insurance Company | MAESTRI, PATRICK J | 3635 | §103§112 | Non-Final OA | 28d | Pending | Jul 23, 2024 |
| 18721735 | SREBP-1 INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTRIGLYCERIDEMIA | Jichi Medical University | WILSON, JERICA KATLYNN | §102 | Non-Final OA | — | Pending | Jun 19, 2024 | |
| 18738997 | BREAST PUMP | Momtech, Inc. | MEDWAY, SCOTT J | DP | Non-Final OA | — | Pending | Jun 10, 2024 | |
| 18678931 | TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS | Incyte Corporation | AULAKH, CHARANJIT | 1621 | §112DP | Non-Final OA | — | Pending | May 30, 2024 |
| 18714055 | MASS ANALYSIS | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | NGUYEN, KIET TUAN | §102 | Non-Final OA | — | Pending | May 28, 2024 | |
| 18649142 | REACTIONS USING FACILITATORS AND MODERATORS | K-Orbital LLC | GARNER, LILY CRABTREE | 3646 | §101§102§103§112 | Non-Final OA | 37d overdue | Pending | Apr 29, 2024 |
| 18639041 | 2-AZABICYCLO[2.2.1]HEPTANE KRAS INHIBITORS | Incyte Corporation | SEAMAN, D MARGARET M | 1625 | §103§112DP | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18698440 | SOFTWARE FOR MICROFLUIDIC SYSTEMS INTERFACING WITH MASS SPECTROMETRY | Intabio, LLC | NIMOX, RAYMOND LONDALE | §101§103 | Non-Final OA | — | Pending | Apr 04, 2024 | |
| 18698102 | METHODS AND SYSTEMS FOR PROCESSING IN REAL-TIME AND USING GAUSSIAN | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | VANORE, DAVID A | 2878 | §112 | Final Rejection | — | Pending | Apr 03, 2024 |
| 18696689 | MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION THERAPY | BIONTECH SE | GUSTILO, ESTELLA M | 1646 | §103 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18694631 | REGENERATIVE AGENT FOR BONE TISSUE AND LUNG TISSUE, AND PHARMACEUTICAL COMPOSITION FOR REGENERATING BONE TISSUE AND LUNG TISSUE | Niigata University | BERRY, LAYLA D | §102 | Non-Final OA | — | Pending | Mar 22, 2024 | |
| 18694663 | MEDICAMENT COMPRISING A P2X4 RECEPTOR ANTAGONIST FOR PREVENTING OR TREATING NOCICEPTIVE PAIN AND/OR VISCERAL PAIN | Nippon Chemiphar Co., Ltd. | RAHMANI, NILOOFAR | 1691 | §102§112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18611933 | ORAL ROOM-TEMPERATURE STABLE YEAST PARTICLES (YP) AND METHODS OF USE | UNIVERSITY OF MASSACHUSETTS | COHEN, MICHAEL P | 1612 | §103§112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18598958 | LIDAR MEMORY BASED SEGMENTATION | Waabi Innovation Inc. | KUAN, JOHN CHUNYANG | §101§112 | Non-Final OA | — | Pending | Mar 07, 2024 | |
| 18689008 | OSTEOARTHRITIS PROGRESSION INHIBITOR AND PROGRESSION INHIBITION KIT | Kyushu University, National University Corporation | LEE, HOI YAN NMN | §103§112 | Non-Final OA | — | Pending | Mar 04, 2024 | |
| 18688485 | METHODS AND SYSTEMS FOR ASSESSING A QUALITY OF MASS ANALYSIS DATA GENERATED BY A MASS SPECTROMETER | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | KORANG-BEHESHTI, YOSSEF | §101§102§103§112 | Non-Final OA | — | Pending | Mar 01, 2024 | |
| 18684682 | COMPOSITION COMPRISING PASTEURIZED AKKERMANSIA FOR THE TREATMENT OR PREVENTION OF IBS-RELATED ANXIETY | The Akkermansia Company | MOREAU, NASHARA LOUISE | 1655 | §101§102§103§112 | Non-Final OA | 8d overdue | Pending | Feb 18, 2024 |
| 18439838 | FUNTIONALLY MODIFIED POLYPEPTIDES AND RADIOBIOSYNTHESIS | Ikaria Inc. | STEELE, AMBER D | 1658 | §102§103§112Other | Non-Final OA | 9d overdue | Pending | Feb 13, 2024 |
| 18439235 | Biological Fluid Concentration Devices and Methods of Use | Arthrex, Inc. | BERA, HENA RAKESHKUMAR | 1779 | §103 | Non-Final OA | — | Pending | Feb 12, 2024 |
| 18439034 | STABILIZATION OF OLIGONUCLEOTIDE AND OLIGONUCLEOTIDE-PROTEIN COMPLEX USING ALKYLATED PHOSPHATE | UNIVERSITY OF MASSACHUSETTS | MCINTOSH III, TRAVISS C | §102 | Non-Final OA | — | Pending | Feb 12, 2024 | |
| 18434227 | TISSUE USE FOR REPAIR OF INJURY | Arthrex, Inc. | DUKERT, BRIAN AINSLEY | DP | Non-Final OA | — | Pending | Feb 06, 2024 | |
| 18426675 | SITE-SPECIFIC CONJUGATION TO ANTIBODY LYSINE RESIDUES WITH SOLID-PHASE IMMOBILIZED MICROBIAL TRANSGLUTAMINASE MTG AND MTG IN SOLUTION | Paul Scherrer Institut | LIEB, JEANETTE M | 1654 | §112DP | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18291808 | LIPID NANOPARTICLE FORMULATIONS | Monash University | WERTZ, ASHLEE ELIZABETH | 1612 | §102§103§112 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18420683 | Preventing Errors in Processing and Interpreting Mass Spectrometry Results | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | KNOX, KALERIA | 2857 | §103 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18571782 | MULTIRESIDUAL METHOD FOR DETECTING AND/OR QUANTIFYING AMINO ACIDS, ORGANIC ACIDS AND/OR MODIFIED NUCLEOTIDES BY MEANS OF HILIC CHROMATOGRAPHIC SEPARATION AND MS/MS | Crescendo Care S.r.l. | MUI, CHRISTINE T | 2855 | §112 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18570745 | CRISPR CASCADE | The Board Of Trustees Of The University Of Illinois | BAUSCH, SARAE L | 1683 | §102§103§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18570201 | MARKER FOR DNA DAMAGE IN PROXIMITY OF TRANSCRIBED GENOMIC LOCI AND METHODS FOR IDENTIFYING AND/OR QUANTIFYING THESE DNA DAMAGES | Fondazione Istituto Italiano Di Tecnologia | HANEY, AMANDA MARIE | 1682 | §101§112 | Final Rejection | — | Pending | Dec 14, 2023 |
| 18569859 | COMPOSITION COMPRISING DRY EXTRACT OF LYOPHILISED INTESTINAL CONTENT OF ADULT CHICKEN, RELATIVE USE AS FOOD SUPPLEMENT AND USE FOR STIMULATING THE IMMUNE SYSTEM | Orbiotek Sàrl | TURNER, FELICIA C | 1793 | §103 | Final Rejection | — | Pending | Dec 13, 2023 |
| 18568404 | MS Calibration for OPI-MS | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | GASSEN, CHRISTOPHER J | 2881 | §103 | Final Rejection | — | Pending | Dec 08, 2023 |
| 18565575 | GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING HYDROXYACID OXIDASE 1 (HAO1) AND USES THEREOF | Arbor Biotechnologies, Inc. | ZARA, JANE J | §112 | Non-Final OA | — | Pending | Nov 30, 2023 | |
| 18522928 | MODULAR PORTABLE POWER SYSTEM FOR SMALL APPLIANCE APPLICATIONS | Bollinger Industries, Inc. | MIKELS, MATTHEW | §102 | Non-Final OA | — | Pending | Nov 29, 2023 | |
| 18561645 | COATING SYSTEM FOR PROTECTING A SUBSTRATE | BEDIMENSIONAL S.P.A. | AHMED, SHEEBA | 1787 | §103 | Final Rejection | 34d | Pending | Nov 16, 2023 |
| 18507340 | NEGATIVE PRESSURE DRAINAGE SYSTEM | Shenzhen Bao'An People'S Hospital | YANG, CHENG FONG | 3781 | §102 | Final Rejection | — | Pending | Nov 13, 2023 |
| 18506668 | COMPACT LIDAR REPRESENTATION | Waabi Innovation Inc. | COFINO, JONATHAN M | 2614 | §103 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18501729 | COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TYPE II PRMT INHIBITOR | Ideaya Biosciences, Inc. | HUTTER, GILLIAN A | 1625 | DP | Non-Final OA | 8d overdue | Pending | Nov 03, 2023 |
| 18555058 | COMBINATION THERAPY COMPRISING A PKC INHIBITOR AND A MEK INHIBITOR | Pfizer, Inc. | O DELL, DAVID K | 1621 | §103 | Non-Final OA | 5d | Pending | Oct 12, 2023 |
| 18375235 | OLIGONUCLEOTIDES TARGETING S6K1 | UNIVERSITY OF MASSACHUSETTS | YU, DELPHINUS DOU YI | 1636 | §103DP | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18375206 | OCULAR DELIVERY OF OLIGONUCLEOTIDES | UNIVERSITY OF MASSACHUSETTS | YU, DAVID TUYANG | 1635 | §102Other | Non-Final OA | 40d | Pending | Sep 29, 2023 |
| 18284952 | THERAPEUTIC INHIBITORS OF GDF15 SIGNALLING | Kymab Limited | LEE, YIE CHIA | 1642 | §112 | Non-Final OA | 23d overdue | Pending | Sep 29, 2023 |
| 18283375 | BIOLOGICAL SAMPLE PREPARATION AND ANALYSIS | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | GABEL, GAILENE | 1678 | §103§112Other | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18551511 | PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 | Almac Discovery Limited | SHIM, DAVID M. | 1626 | §102§112 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18281722 | System and Method for Variable FFT Analysis Windows in Mass Spectrometry | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | CHOI, JAMES J | 2878 | §103 | Final Rejection | — | Pending | Sep 12, 2023 |
| 18549454 | SYSTEMS AND METHODS FOR THE PREPARATION OF ENRICHED SERUM | Arthrex, Inc. | LYLE, SOPHIA YUAN | 1796 | §103§112 | Non-Final OA | — | Pending | Sep 07, 2023 |
| 18548708 | CAPILLARY ELECTROPHORESIS METHODS FOR QUANTIFYING VIRAL SPECIES | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | SIFFORD, JEFFREY MARK | 1671 | §103§112Other | Non-Final OA | 77d | Pending | Sep 01, 2023 |
| 18459412 | SPRING PLATE FOR ATHLETIC SHOE MIDSOLE | Hettas Sport Ltd. | NUNNERY, GRADY ALEXANDER | 3732 | §103 | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18453098 | FCRN BINDING POLYPEPTIDES | The Board Of Trustees Of The University Of Illinois | GUSTILO, ESTELLA M | 1646 | §102§103§112 | Final Rejection | — | Pending | Aug 21, 2023 |
| 18361156 | MODULAR MULTI-PANEL SOLAR CELL | 4D Vision Corp. | CANNON, RYAN SMITH | 1726 | §102§103 | Non-Final OA | 114d overdue | Pending | Jul 28, 2023 |
| 18226834 | YEAST PARTICLES FOR DELIVERY OF WATER-ACTIVATED SELF-EMULSIFYING CANNABINOID FORMULATIONS | UNIVERSITY OF MASSACHUSETTS | SCOTLAND, REBECCA LYNN | 1791 | §102§103§112DP | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18274624 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | UNIVERSITAET ULM | NICKOL, GARY B | 1643 | §101§102§112DP | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18040321 | TESTING DEVICE WITH BUILT-IN LIQUID STORAGE | AusMed Global Limited | MUI, CHRISTINE T | 1797 | §102§112 | Non-Final OA | 29d | Pending | Jul 14, 2023 |
| 18271660 | MARKER FOR ASSISTING IN DIAGNOSIS OF NEPHROTIC SYNDROME AND USE THEREOF | Niigata University | NGUYEN, NAM P | 1678 | §101§103§112 | Final Rejection | — | Pending | Jul 10, 2023 |
| 18341210 | BOYSENBERRY COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | The New Zealand Institute for Plant and Food Research Limited | VISONE, THOMAS J | 1672 | DPOther | Non-Final OA | 70d | Pending | Jun 26, 2023 |
| 18259327 | POLY-ION COMPLEX MICELLE | Kawasaki Institute Of Industrial Promotion | SCOTLAND, REBECCA LYNN | 1615 | §103§112 | Final Rejection | — | Pending | Jun 26, 2023 |
| 18257177 | BI-FUNCTIONAL LINEAR FUSION COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF | Cullinan Amber Corp. | CESARE, JOSEPH DAVID | 1675 | §103§112 | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18255420 | PRODUCTION OF FUNGAL BIOMASS | Mushlabs GmbH | ARIANI, KADE | 1651 | — | Final Rejection | 17d overdue | Pending | Jun 01, 2023 |
| 18039091 | NON AGGREGATING MICROFLUIDIC MIXER AND METHODS THEREFOR | Global Life Sciences Solutions Canada Ulc | INSLER, ELIZABETH | 1774 | §102§103 | Final Rejection | 11d overdue | Pending | May 26, 2023 |
| 18038818 | ANTIBODY AND TAXANE COMBINATION THERAPY | Genmab A/S | JUEDES, AMY E | 1644 | §103§112DPOther | Final Rejection | 75d | Pending | May 25, 2023 |
| 18322675 | SYSTEMS, METHODS, AND COMPOSITIONS FOR RNA-GUIDED RNA-TARGETING CRISPR EFFECTORS | The University of Tokyo | GROOMS, TIFFANY NICOLE | 1637 | §103§112 | Non-Final OA | 42d | Pending | May 24, 2023 |
| 18201626 | USE OF ANTI-IL-27 ANTIBODIES | F. Hoffmann-La Roche AG | JOHNSON, TIRONE DEREK | 1675 | §103§112 | Non-Final OA | 45d overdue | Pending | May 24, 2023 |
| 18321971 | OPTIMIZED ANTI-FLT1 OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | CHONG, KIMBERLY | 1636 | §112 | Non-Final OA | — | Pending | May 23, 2023 |
| 18318915 | MULTILAYERED CONFECTIONARY | Ferrara Candy Company | BEKKER, KELLY JO | 1792 | §103 | Final Rejection | 16d overdue | Pending | May 17, 2023 |
| 18197948 | OPTIMIZED SIRNA SCAFFOLDS | UNIVERSITY OF MASSACHUSETTS | GROOMS, TIFFANY NICOLE | 1637 | §102§103§112DP | Non-Final OA | — | Pending | May 16, 2023 |
| 18252904 | NEAR INFRARED-II PROBES AS HIGH AFFINITY TARGETING IMAGING AGENTS AND USES THEREOF | On Target Laboratories, LLC | AEDER, SEAN E | 1642 | §102§103 | Non-Final OA | 1d overdue | Pending | May 15, 2023 |
| 18252896 | METHOD FOR DETECTING AND/OR QUANTIFYING A METAL ELEMENT IN A BIOLOGICAL LIQUID | Cardiovascular Lab S.r.l. | GAMBLE JR, RANDALL LEE | 1795 | §103 | Non-Final OA | 14d | Pending | May 15, 2023 |
| 18036144 | FUSION PROTEIN TARGETING BOTH CD3 AND CD137, PREPARATION METHOD THEREFOR AND USE THEREOF | BEIJING IMMUNOAH PHARMATECH CO., LTD. | MOSELEY II, NELSON B | 1642 | §103§112 | Non-Final OA | — | Pending | May 09, 2023 |
| 18142852 | OLIGONUCLEOTIDES FOR PMS1 MODULATION | UNIVERSITY OF MASSACHUSETTS | TRAN, CHRISTINA L | 1637 | §101§103§112 | Non-Final OA | 62d | Pending | May 03, 2023 |
| 18251493 | A PROCESS FOR PRODUCING EGF | Chemical & Biopharmaceutical Laboratories Of Patras S.A. | DABKOWSKI, ERINNE R | 1654 | §103§112 | Non-Final OA | — | Pending | May 02, 2023 |
| 18140908 | SELECTIVE RNA-MODULATING AGENTS | UNIVERSITY OF MASSACHUSETTS | GROOMS, TIFFANY NICOLE | 1637 | §103§112DP | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18141166 | PROTECTING OLIGONUCLEOTIDES FOR CRISPR GUIDE RNA | UNIVERSITY OF MASSACHUSETTS | MEYERING, SHABANA SHABBEER | 1635 | §102§103§112 | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18303346 | COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | Als Therapy Development Institute | SABILA, MERCY HELLEN | 1654 | §103§112DP | Non-Final OA | 60d overdue | Pending | Apr 19, 2023 |
| 18134167 | OLIGONUCLEOTIDES FOR ATN1 MODULATION | UNIVERSITY OF MASSACHUSETTS | MCLEOD, AFRICA MHAIRIE | 1635 | §101§102§103§112 | Non-Final OA | 26d | Pending | Apr 13, 2023 |
| 18299344 | ARTIFICIAL INTELLIGENCE HEALTH DIAGNOSTIC SYSTEM AND METHOD | Evan Greebel | AKOGYERAM II, NICHOLAS A | 3686 | §101 | Final Rejection | 70d | Pending | Apr 12, 2023 |
| 18299304 | THERAPEUTIC RADIOLABELLED CONJUGATES AND THEIR USE IN THERAPY | University Of Sydney | CRAIG, KAILA ANGELIQUE | 1618 | §103DP | Final Rejection | 23d overdue | Pending | Apr 12, 2023 |
| 18193958 | METHODS OF TREATING ENHANCING BRAIN TUMORS USING COMBINATION THERAPY | Servier Pharmaceuticals Llc. | TRAN HO, LAM THUY VI | 1647 | §103Other | Non-Final OA | 23d overdue | Pending | Mar 31, 2023 |
| 18029725 | SIRT1 INHIBITOR OR ANTAGONIST FOR USE IN PREVENTING AND/OR TREATING AN HPV INDUCED TUMOUR | UNIVERSITA' DEGLI STUDI DEL PIEMONTE ORIENTALE "A. AVOGADRO" | GIBBS, TERRA C | 1635 | §102§103§112 | Final Rejection | 3d overdue | Pending | Mar 31, 2023 |
| 18028702 | ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS SPECIFICALLY BINDING TO GREMLIN-1 AND USES THEREOF | Kantonsspital St. Gallen | HADDAD, MAHER M | 1641 | §102§112Other | Non-Final OA | 19d | Pending | Mar 27, 2023 |
| 18027306 | METHOD FOR PREPARING EFFECTOR CELLS WITH DESIRED SPECIFICITY | National University Corporation Shiga University Of Medical Science | ZHU, JIANJIAN | 1631 | §103§112Other | Final Rejection | 2d overdue | Pending | Mar 20, 2023 |
| 18120030 | OLIGONUCLEOTIDES FOR APP MODULATION | UNIVERSITY OF MASSACHUSETTS | ALLEN, SARAH ELIZABETH | 1637 | §102§103§112 | Non-Final OA | 2d overdue | Pending | Mar 10, 2023 |
| 18025503 | METHOD FOR PRODUCING CENTRE FILLED GUMMIES COMPRISING FILLINGS | Rousselot BV | KIM, DANIELLE A | 1613 | §103§112 | Final Rejection | — | Pending | Mar 09, 2023 |
| 18177430 | TRANSGLUTAMINASE CONJUGATION METHOD WITH AMINO ACID-BASED LINKERS | Araris Biotech AG | WESTERBERG, NISSA M | 1618 | §102§103§112DP | Non-Final OA | — | Pending | Mar 02, 2023 |
| 18041918 | TRANSFORMABLE PNEUMATIC SOFT STRUCTURES | Massachusetts Institute Of Technology | LEDERER, SARAH B | 3785 | §103 | Final Rejection | 30d | Pending | Feb 16, 2023 |
| 18108961 | PROTEINS BINDING NKG2D, CD16 AND NECTIN4 | Dragonfly Therapeutics, Inc. | BRISTOL, LYNN ANNE | 1643 | §103 | Final Rejection | 1d overdue | Pending | Feb 13, 2023 |
| 18107292 | MULTISPECIFIC BINDING PROTEINS TARGETING CEA | Dragonfly Therapeutics, Inc. | HUYNH, PHUONG N | 1641 | §103§112 | Non-Final OA | — | Pending | Feb 08, 2023 |
| 18040171 | METHODS OF TREATMENT USING FUROSEMIDE | Scpharmaceuticals Inc. | CORNET, JEAN P | 1628 | §103 | Non-Final OA | — | Pending | Feb 01, 2023 |
| 18009498 | ISOTHERMAL REAL-TIME PCR METHOD FOR DETERMINING PRESENCE OF A PRE-DETERMINED NUCLEIC ACID SEQUENCE IN ANIMAL SAMPLES | Ender Holding AG | HOPPE, EMMA RUTH | 1683 | §101§102§103§112Other | Non-Final OA | 8d overdue | Pending | Dec 09, 2022 |
| 18062311 | CENTRIFUGE APHERETIC SYSTEM | Astrin Biosciences, Inc. | KASS, BENJAMIN JOSEPH | 1798 | §102§103§112 | Non-Final OA | 35d overdue | Pending | Dec 06, 2022 |
| 18062326 | HYDRO-CYCLONE CENTRIFUGE APHERETIC SYSTEM | Astrin Biosciences, Inc. | MELLON, DAVID C | 1700 | §102§112 | Final Rejection | — | Pending | Dec 06, 2022 |
| 18071590 | THERMODYNAMIC MEASURES ON PROTEIN-PROTEIN INTERACTION NETWORKS FOR CANCER THERAPY | Csts Health Care Inc. | ROSSI, VY BUI | §101§103§112DP | Non-Final OA | — | Pending | Nov 29, 2022 | |
| 18058059 | ANTI-VIRAL DRY CLEANING PROCESS | Greenearth Cleaning, LLC | YOO, REGINA M | 1758 | §103§112 | Final Rejection | — | Pending | Nov 22, 2022 |
| 17999013 | METHODS OF TREATING OR PREVENTING ORGANOPHOSPHORUS POISONING | Lachesis Biosciences Limited | HIRAKIS, SOPHIA P | 1623 | §103DP | Final Rejection | — | Pending | Nov 16, 2022 |
| 17999001 | N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 | Pathios Therapeutics Limited | BAUER, NICOLA MARIA | 1621 | §103DPOther | Final Rejection | 36d overdue | Pending | Nov 16, 2022 |
| 17998574 | POLYNUCLEOTIDES COMPRISING AN ANTIGENIC PAYLOAD | Nutcracker Therapeutics, Inc. | DENT, ALANA HARRIS | 1643 | §102§103§112 | Non-Final OA | — | Pending | Nov 11, 2022 |
| 17998613 | CONCENTRATED COMPOSITIONS OF PROTEINS, THEIR PREPARATION AND USE THEREOF | Hoffmann-La Roche, Inc. | WHITE, ASHLEY TAYLOR | 1653 | §103 | Final Rejection | — | Pending | Nov 11, 2022 |
| 17922262 | INFLUENZA VIRUS PRODUCTION METHOD USING SINGLE-USE CULTURE PROCESS SYSTEM AND RAPID CONFIRMATION TEST OF INFLUENZA VIRUS ANTIGEN PURIFICATION CONDITION | SK Bioscience Co., Ltd. | WANG, RUIXUE | 1672 | §101§103§112 | Final Rejection | — | Pending | Oct 28, 2022 |
| 18049724 | COMPLEXES FOR GENE DELETION AND EDITING | UNIVERSITY OF MASSACHUSETTS | LEONARD, ARTHUR S | 1631 | §103 | Final Rejection | 11d overdue | Pending | Oct 26, 2022 |
| 17996126 | LONG ACTING GLUCAGON RECEPTOR SELECTIVE PEPTIDES AND METHODS OF USE | I2O Therapeutics, Inc. | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §102§103§112Other | Non-Final OA | 49d overdue | Pending | Oct 13, 2022 |
| 17937778 | RADIATION SENSITIVITY ENHANCING COMOPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | Korea Institute Of Radiological & Medical Sciences | THOMAS, TIMOTHY P | 1614 | §103Other | Non-Final OA | 72d overdue | Pending | Oct 03, 2022 |
| 17915361 | MEDICAMENT FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME OR INFLAMMATORY BOWEL DISEASE | Nippon Chemiphar Co., Ltd. | CHANDRAKUMAR, NIZAL S | 1625 | §103DP | Final Rejection | 67d overdue | Pending | Sep 28, 2022 |
| 17940636 | VIRAL GUIDE RNA DELIVERY | BEAM THERAPEUTICS INC. | DHAR, MATASHA | 1632 | §102§103§112 | Non-Final OA | — | Pending | Sep 08, 2022 |
| 17884998 | SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF TUMORS | Purdue Research Foundation | PERREIRA, MELISSA JEAN | 1618 | §103DPOther | Non-Final OA | 62d | Pending | Aug 10, 2022 |
| 17817033 | MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 | BIONTECH SE | KAUFMAN, CLAIRE M | 1674 | §103DP | Final Rejection | — | Pending | Aug 03, 2022 |
| 17796953 | METHOD FOR FUNCTIONALISING A CELLULOSE SUPPORT WITH METAL NANOPARTICLES AND ELECTROANALYTICAL SENSOR COMPRISING THE FUNCTIONALISED CELLULOSE SUPPORT | Cardiovascular Lab S.p.A. | GAMBLE JR, RANDALL LEE | 1795 | §103 | Non-Final OA | 46d overdue | Pending | Aug 02, 2022 |
| 17787545 | NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES | GE Healthcare AS | ROGERS, JAMES WILLIAM | 1618 | §103 | Non-Final OA | 23d | Pending | Jun 20, 2022 |
| 17778902 | SOFTWARE FOR MICROFLUIDIC SYSTEMS INTERFACING WITH MASS SPECTROMETRY | Intabio, LLC | DESTA, ELIAS | 2857 | §101 | Final Rejection | — | Pending | May 23, 2022 |
| 17769657 | METHOD FOR PRODUCING RADIOACTIVE METAL-LABELED ANTIBODY | Nihon Medi-Physics Co., Ltd. | JONES, DAMERON LEVEST | 1618 | §103§112Other | Final Rejection | — | Pending | Apr 15, 2022 |
| 17704915 | OLIGONUCLEOTIDES FOR SYNGR-3 MODULATION | UNIVERSITY OF MASSACHUSETTS | VYAS, KEYUR ANILKUMAR | 1637 | §103§112 | Non-Final OA | 9d | Pending | Mar 25, 2022 |
| 17753034 | LC Issue Diagnosis from Pressure Trace Using Machine Learning | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | JEONG, YOUNGSUL | 1772 | §103 | Non-Final OA | — | Pending | Feb 16, 2022 |
| 17575039 | NOVEL USE OF REGULATORY T CELL-SPECIFIC SURFACE PROTEIN LRIG-1 | Good T Cells, Inc. | JUEDES, AMY E | 1644 | §112 | Non-Final OA | — | Pending | Jan 13, 2022 |
| 17624690 | COMBINATION | Genesis Pharma SA | D' AMBROSIO, THEA | 1654 | §102§112Other | Non-Final OA | 55d | Pending | Jan 04, 2022 |
| 17532636 | OLIGONUCLEOTIDES FOR DGAT2 MODULATION | UNIVERSITY OF MASSACHUSETTS | ARIETI, RUTH SOPHIA | 1635 | §103Other | Non-Final OA | 2d overdue | Pending | Nov 22, 2021 |
| 17603808 | METHOD AND KIT FOR DETECTING RISK OF COLORECTAL CANCER | Keio University | JOHANNSEN, DIANA B | 1682 | §103§112 | Final Rejection | — | Pending | Oct 14, 2021 |
| 17599282 | XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF | The Governors of the University of Alberta | HIBSHMAN, SARAH GRACE | 1693 | §103 | Non-Final OA | — | Pending | Sep 28, 2021 |
| 17466516 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | Wageningen Universiteit | GOUGH, TIFFANY MAUREEN | 1651 | §103§112Other | Final Rejection | — | Pending | Sep 03, 2021 |
| 17262400 | METHOD FOR PRODUCING FOREIGN ANTIGEN RECEPTOR GENE-INTRODUCED CELL | National University Corporation Shiga University Of Medical Science | MIANO, JOSEPH PAUL | 1631 | §102§103§112Other | Non-Final OA | 87d overdue | Pending | Aug 27, 2021 |
| 17430998 | PREDICTIVE TEST FOR IDENTIFICATION OF EARLY STAGE NSCLC STAGE PATIENTS AT HIGH RISK OF RECURRENCE AFTER SURGERY | BIODESIX, INC. | STUBBS, JOHN THOMAS | 1686 | §101§103§112 | Final Rejection | — | Pending | Aug 13, 2021 |
| 17429754 | PLASMA POLYMER NANOPARTICLES CARRYING AGENTS | The Heart Research Institute Ltd. | PATTERSON, SARAH COOPER | 1675 | DP | Final Rejection | — | Pending | Aug 10, 2021 |
| 17415842 | ULTRASOUND CONTRAST AGENT AND METHODS FOR USE THEREOF | GE Healthcare AS | CRAIG, KAILA ANGELIQUE | 1618 | §103§112 | Non-Final OA | — | Pending | Jun 18, 2021 |
| 17318846 | MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING | UNIVERSITY OF MASSACHUSETTS | ZARA, JANE J | 1637 | §112 | Final Rejection | — | Pending | May 12, 2021 |
| 17313421 | Biological Fluid Filtration System | Astrin Biosciences, Inc. | LYLE, SOPHIA YUAN | 1796 | §103 | Non-Final OA | 30d overdue | Pending | May 06, 2021 |
| 17285356 | INTEIN PROTEINS AND USES THEREOF | Fondazione Telethon | GU, QINHUA | 1633 | §103§112 | Final Rejection | — | Pending | Apr 14, 2021 |
| 16999759 | O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES | UNIVERSITY OF MASSACHUSETTS | ARIETI, RUTH SOPHIA | 1635 | §103DPOther | Non-Final OA | — | Pending | Aug 21, 2020 |
| 16998587 | TARGETED FLUORESCENT MARKERS IN COMBINATION WITH A FLEXIBLE PROBE | On Target Laboratories, LLC | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | 162d overdue | Pending | Aug 20, 2020 |
| 15555811 | MICROPARTICLES | Spheritech Ltd. | LOVE, TREVOR M | 1611 | §102Other | Final Rejection | 11d overdue | Pending | Sep 05, 2017 |
| 14390495 | KETONE BODIES AND KETONE BODY ESTERS FOR MAINTAINING OR IMPROVING MUSCLE POWER OUTPUT | Tdeltas Limited | LEE, WILLIAM Y | 1623 | §103Other | Non-Final OA | — | Pending | Oct 03, 2014 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial